Cargando…
Chitosan-Poly (I:C)-PADRE Based Nanoparticles as Delivery Vehicles for Synthetic Peptide Vaccines
The safety and precision of peptide antigens has prompted the search for adjuvants capable of increasing the immune response against these intrinsically poorly immunogenic antigens. The integration of both immunostimulants and peptide antigens within nanometric delivery systems for their co-delivery...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586475/ https://www.ncbi.nlm.nih.gov/pubmed/26378586 http://dx.doi.org/10.3390/vaccines3030730 |
_version_ | 1782392365986611200 |
---|---|
author | Correia-Pinto, Jorge F. Csaba, Noemi Schiller, John T. Alonso, Maria J. |
author_facet | Correia-Pinto, Jorge F. Csaba, Noemi Schiller, John T. Alonso, Maria J. |
author_sort | Correia-Pinto, Jorge F. |
collection | PubMed |
description | The safety and precision of peptide antigens has prompted the search for adjuvants capable of increasing the immune response against these intrinsically poorly immunogenic antigens. The integration of both immunostimulants and peptide antigens within nanometric delivery systems for their co-delivery to immune cells is a promising vaccination strategy. With this in mind, the potential synergistic effect of the immunostimulant poly (I:C) (pIC) and a T-Helper peptide (PADRE), integrated into a chitosan (CS) based nanostructure, was explored. The value of this nanostructured combination of materials was assessed for a peptide antigen (1338aa) derived from the HPV-16 L2 protein. These nanoparticles, produced by ionic gelation technique, exhibited a nanometric size (<300 nm), a high positive surface charge (>40 mV) and high pIC association efficiency (>96%). They also showed capacity for the association of both the 1338aa and PADRE peptides. The influence of the presence of pIC and PADRE in the nanocomposition, as well as that of the peptide presentation form (encapsulated versus surface adsorbed) on the antibody induction was evaluated in a preliminary in vivo study. The data obtained highlights the possibility to engineer nanoparticles through the rational combination of a number of adjuvant molecules together with the antigen. |
format | Online Article Text |
id | pubmed-4586475 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-45864752015-10-06 Chitosan-Poly (I:C)-PADRE Based Nanoparticles as Delivery Vehicles for Synthetic Peptide Vaccines Correia-Pinto, Jorge F. Csaba, Noemi Schiller, John T. Alonso, Maria J. Vaccines (Basel) Article The safety and precision of peptide antigens has prompted the search for adjuvants capable of increasing the immune response against these intrinsically poorly immunogenic antigens. The integration of both immunostimulants and peptide antigens within nanometric delivery systems for their co-delivery to immune cells is a promising vaccination strategy. With this in mind, the potential synergistic effect of the immunostimulant poly (I:C) (pIC) and a T-Helper peptide (PADRE), integrated into a chitosan (CS) based nanostructure, was explored. The value of this nanostructured combination of materials was assessed for a peptide antigen (1338aa) derived from the HPV-16 L2 protein. These nanoparticles, produced by ionic gelation technique, exhibited a nanometric size (<300 nm), a high positive surface charge (>40 mV) and high pIC association efficiency (>96%). They also showed capacity for the association of both the 1338aa and PADRE peptides. The influence of the presence of pIC and PADRE in the nanocomposition, as well as that of the peptide presentation form (encapsulated versus surface adsorbed) on the antibody induction was evaluated in a preliminary in vivo study. The data obtained highlights the possibility to engineer nanoparticles through the rational combination of a number of adjuvant molecules together with the antigen. MDPI 2015-09-11 /pmc/articles/PMC4586475/ /pubmed/26378586 http://dx.doi.org/10.3390/vaccines3030730 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Correia-Pinto, Jorge F. Csaba, Noemi Schiller, John T. Alonso, Maria J. Chitosan-Poly (I:C)-PADRE Based Nanoparticles as Delivery Vehicles for Synthetic Peptide Vaccines |
title | Chitosan-Poly (I:C)-PADRE Based Nanoparticles as Delivery Vehicles for Synthetic Peptide Vaccines |
title_full | Chitosan-Poly (I:C)-PADRE Based Nanoparticles as Delivery Vehicles for Synthetic Peptide Vaccines |
title_fullStr | Chitosan-Poly (I:C)-PADRE Based Nanoparticles as Delivery Vehicles for Synthetic Peptide Vaccines |
title_full_unstemmed | Chitosan-Poly (I:C)-PADRE Based Nanoparticles as Delivery Vehicles for Synthetic Peptide Vaccines |
title_short | Chitosan-Poly (I:C)-PADRE Based Nanoparticles as Delivery Vehicles for Synthetic Peptide Vaccines |
title_sort | chitosan-poly (i:c)-padre based nanoparticles as delivery vehicles for synthetic peptide vaccines |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586475/ https://www.ncbi.nlm.nih.gov/pubmed/26378586 http://dx.doi.org/10.3390/vaccines3030730 |
work_keys_str_mv | AT correiapintojorgef chitosanpolyicpadrebasednanoparticlesasdeliveryvehiclesforsyntheticpeptidevaccines AT csabanoemi chitosanpolyicpadrebasednanoparticlesasdeliveryvehiclesforsyntheticpeptidevaccines AT schillerjohnt chitosanpolyicpadrebasednanoparticlesasdeliveryvehiclesforsyntheticpeptidevaccines AT alonsomariaj chitosanpolyicpadrebasednanoparticlesasdeliveryvehiclesforsyntheticpeptidevaccines |